Cargando…
A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma
Glioblastoma (GBM) is an aggressive tumor of the central nervous system that has poor prognosis despite extensive therapy. Therefore, it is essential to identify a gene expression-based signature for predicting GBM prognosis. The RNA sequencing data of GBM patients from the Chinese Glioma Genome Atl...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385312/ https://www.ncbi.nlm.nih.gov/pubmed/30796273 http://dx.doi.org/10.1038/s41598-019-39273-4 |